The Globe and Mail
· collected 2026-10-08 · by Alanna Smith, Kristy Kirkup
Alex Shved, a 37-year-old father with Stage 4 melanoma from Ontario, remains unable to receive coverage for an experimental treatment called TIL therapy after the provincial government revised its health insurance rules in October. Previously, Ontario’s Superior Court had overturned the province's decision to deny Mr. Shved access to this U.S.-based treatment, but new amendments maintain that only certain conditions qualify for out-of-country medical coverage. The province cites potential financial risks as justification for these stringent requirements, estimating possible yearly costs of $5.2 billion if it did not update its policy. Mr. Shved and his supporters argue the revised rules are inadequate and hinder access to vital treatments.
Written locally by qwen2.5:14b on 2026-10-08,
using this article's own text rather than the other coverage of the
same event (that is the story summary below).
Story summary
Alex Shved, a 37-year-old father of two from Ontario with Stage 4 melanoma, is dismayed after the provincial government announced revised rules for out-of-country medical coverage that continue to deny him access to critical treatment. In September, the Ontario Superior Court of Justice quashed the province's decision to refuse funding for his specific treatment. However, on Tuesday, the government released amendments clarifying conditions under which it will fund treatments abroad. These conditions stipulate that the drug and its administration must already be funded in Ontario, the treatment itself must occur there, access must temporarily be unavailable locally, and travel is necessary to avoid death or irreversible tissue damage. Despite these changes, Shved's treatment still does not qualify for coverage, leaving him feeling "incredibly disappointed" that residents cannot receive vital treatments promptly.
Written for “Ontario Healthcare Coverage Rules” on 2026-10-08,
grounded in this article and the 0 other(s) covering the same event.
Why this leaning score
The model judged this article politically coded and scored it -0.35, but all 3 of its quote(s) are attributed speech - words the article quotes from someone, not the article's own narration, so the score is not published.
Written under an earlier scoring contract, which gave a paragraph
rather than checkable quotes. Re-analysing this article replaces it.
Leaning score withheld for article 64367: attributed speech only · logged 2026-10-08
An Ontario father of two with Stage 4 melanoma says he is heartbroken that the provincial government’s revised rules for out-of-country medical coverage will continue to bar access to a treatment that could save his and others’ lives.
uncertain
that → say → lives
Previously, the Ontario Superior Court of Justice in September quashed the province’s decision to refuse to cover that treatment for 37-year-old Alex Shved.
asserted
Court → quash → Shved
On Tuesday, the provincial government announced amendments to its health insurance legislation to clarify when it will cover treatments abroad.
asserted
it → announce → treatments
Under the revised rules, Mr. Shved’s treatment will still not qualify.
asserted
treatment → revise → rules
The province said funding will only be available under certain conditions, including that the drug and its administration are already funded in Ontario, the treatment is performed in Ontario, access is temporarily unavailable, and travelling is necessary to avoid death or medically significant, irreversible tissue damage.
asserted
travelling → say → death
On Wednesday, Mr. Shved said it is “incredibly disappointing” that Ontario has taken this path, rather than helping residents like himself access vital treatments in a timely manner.
asserted
residents → say → manner
“I hoped this court battle would move things in the right direction.
asserted
battle → hop → direction
I didn’t realize how easily they could change the rules so that the result is still the same,” he said, expressing frustration with Premier Doug Ford and Health Minister Sylvia Jones.
uncertain
he → realize → Ford
In a statement, Ontario said it needed to clarify its out-of-country drug funding policy, in place since 2011, because it could expose the province to financial risk.
uncertain
it → say → risk
Failing to update the regulation could cost Ontario’s drug plan $5.2-billion yearly and “create a back door for global pharmaceutical companies to avoid negotiating directly with the province to achieve more competitive pricing,” it said.
uncertain
it → fail → pricing
In response to the September court decision, the government said it is “exploring all available options,” including an appeal or seeking a “mutually satisfactory resolution” with Mr. Shved.
asserted
it → say → Shved
The Etobicoke father is desperate to access tumour-infiltrating lymphocyte, or TIL, therapy, which is a treatment for metastatic melanoma that uses the cells of one of his own tumours.
asserted
that → access → tumours
Mr. Shved applied to Ontario’s out-of-country program to see whether the province would pay for him to be treated in the United States.
asserted
him → apply → States
His application was rejected and he was told the program isn’t intended to be used as an interim funding route for drugs that could eventually qualify for public coverage.
uncertain
that → reject → coverage
In August, 2025, Health Canada approved a commercial version of TIL therapy called lifileucel.
asserted
Canada → approve → therapy
A single treatment of lifileucel costs US$515,000, not including the cost of a stay at a U.S. hospital.
asserted
treatment → cost → hospital
It is not available in Canada outside of clinical trials because it is still being reviewed for public funding.
asserted
it → review → funding
Ms. Jones said in a statement that the regulatory change strikes a balance between protecting Ontario taxpayers and providing access to life-saving medications.
asserted
change → say → medications
She said the change “supports a consistent, fair and transparent approach to funding decisions” and “protects the integrity of Ontario’s world-class drug approval process.”
asserted
change → say → process
Decisions about coverage will continue through the established application process.
asserted
Decisions → continue → process
In the Ontario Superior Court of Justice ruling, justices Jean‑Marc Labrosse and Sharon Shore said the province’s reasons for denying funding to Mr. Shved were unreasonable and inadequately explained, adding that he will “likely be dead by Christmas” without the requested treatment.
asserted
he → say → treatment
They sent the matter back to the executive officer of the Ontario Public Drug Programs and requested a new decision with an expedited timeline.
asserted
They → send → timeline
A third judge, David Corbett, concurred that the decision should be nullified but disagreed on the approach supported by his colleagues.
asserted
decision → concur → colleagues
He wrote that he would have directed the executive officer to recommend treatment and would have instructed the general manager of the Ontario Health Insurance Plan to expedite a funding decision.
asserted
he → write → decision
The Aporia
